Maraviroc and NeuroAIDS Pathogenesis
Phase of Trial: Phase II/III
Latest Information Update: 06 Jan 2017
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 11 Mar 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 17 Mar 2015 Planned initiation date changed from 1 Jul 2014 to 1 May 2015 as reported by ClinicalTrials.gov record.